Positron emission tomography study of changes in [11C]AZ14132516 uptake following administration of AZD7798 to patients with Crohn’s disease.

Trial Identifier:	D9690C00007
Sponsor:	AstraZeneca
Start Date:	October 2024
Primary Completion Date:	April 2026
Study Completion Date:	April 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
SE	Stockholm, SE, 14186

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.